Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Chuanxiong Tablets for Stable Angina Pectoris (Coronary Heart Disease) – Phase 4, Randomized Double-Blind Placebo-Controlled Trial
ChiCTR2600118679Phase 4Not yet recruiting
- Sponsor
- Beijing University of Chinese Medicine
- Start
- Feb 2026
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in stable angina and coronary arteriosclerosis comparing Experimental – Compound Chuanxiong Tablets with Control – Placebo simulant (2 arms). Primary endpoint: Change in Seattle Angina Questionnaire total score at 8 weeks vs baseline. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
compound chuanxiong tablets
03
Conditions
stable anginacoronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2600118679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600118679.